je.st
news
Tag: medicines
Chevron and Medicines are big market movers
2015-09-01 00:46:46| Energy - Topix.net
Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market: Oil stocks tracked the price of crude, which shook off early losses and rallied on a report of a June drop in U.S. production. The coal mining company is extending its private debt exchange offer, which had been set to expire Friday, to September 23. The direct-to-consumer products and marketing company is being sold to asset manager The Carlyle Group for $98 million.
Tags: big
market
medicines
movers
Alnylam, Medicines cholesterol drug lasts months after one shot
2015-08-30 11:16:29| Biotech - Topix.net
LONDON: A new drug in early development cuts cholesterol as much as two potent injections recently cleared for sale but lasts much longer, meaning it may need to be given only every three to six months, initial findings suggest. Results with Alnylam Pharmaceuticals and Medicines Co's experimental product ALN-PCSsc highlight the competition for a market tipped to generate billions of dollars in sales.
Tags: months
drug
shot
cholesterol
Merck Announces European Medicines Agency Acceptance of Marketing Authorization Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection
2015-07-23 17:02:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for grazoprevir/elbasvir (100mg/50mg), an investigational, once-daily, single-tablet combination therapy for the treatment of adult patients with chronic hepatitis C (HCV) genotypes (GT) 1, 3, 4 or 6 infection.1 The EMA will initiate review of the MAA under accelerated assessment timelines. Language: English Contact: Merck & Co., Inc.Media:Doris Li, 908-246-5701orSarra Herzog, 201-669-6570orInvestor:Joe Romanelli, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
application
marketing
treatment
Biogen and Sobi Announce European Medicines Agency Validates...
2015-06-26 10:44:02| Appliances - Topix.net
CAMBRIDGE, Mass. & STOCKHOLM-- -- Biogen and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has accepted the Marketing Authorization Application of ALPROLIX A , a recombinant factor IX Fc fusion protein product candidate for the treatment of hemophilia B. This validation signifies the initiation of the EMA's review process.
Tags: agency
european
announce
medicines
Rationally Designed Antifungal Compounds That Evade Resistance Reported In Nature Chemical Biology By Scientific Founder Of REVOLUTION Medicines
2015-06-03 06:03:53| drugdiscoveryonline Home Page
REVOLUTION Medicines, Inc., a company focused on the discovery and development of innovative drugs derived from natural compounds, announced that progress in antimicrobial drug discovery was published recently in Nature Chemical Biology by the company’s academic founder and scientific advisory board chairman, Martin D. Burke, M.D., Ph.D., professor of chemistry, University of Illinois at Urbana-Champaign, and Early Career Scientist of the Howard Hughes Medical Institute
Tags: designed
nature
reported
scientific
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] next »